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Abstract
Background:  Genetic heterogeneity and complex biologic mechanisms of blood pressure
regulation pose significant challenges to the identification of susceptibility loci influencing
hypertension. Previous linkage studies have reported regions of interest, but lack consistency
across studies. Incorporation of covariates, in particular the interaction between two independent
risk factors (gender and BMI) greatly improved our ability to detect linkage.
Results: We report a highly significant signal for linkage to chromosome 2p, a region that has been
implicated in previous linkage studies, along with several suggestive linkage regions.
Conclusion: We demonstrate the importance of including covariates in the linkage analysis when
the phenotype is complex.
Background
Major risk factors for cardiovascular disease (CVD)
include hypertension and obesity, both of which are com-
plex and heterogeneous. It is estimated that hypertension
affects ~50 million adult Americans [1]. Although obesity
[2] has been identified as a risk factor for hypertension,
the exact causes of hypertension are unknown. Both con-
ditions often coexist, suggesting that shared environmen-
tal and genetic influences may impact both traits.
Population-based samples, such as the Framingham Heart
Study, will include sets of individuals with different
causes of disease, obscuring evidence of linkage to a par-
ticular gene if this heterogeneity is not taken into account
in the linkage analysis.
We investigated hypertension as a dichotomous pheno-
type in the Genetic Analysis Workshop (GAW) 13 data set
from the Framingham Heart Study. To allow for genetic
heterogeneity, we utilized a covariate-based affected rela-
tive pair (ARP) approach [3] using obesity [measured by
body mass index (BMI)], gender, and the interaction of
BMI and gender as covariates, to identify candidate
regions for hypertension. We show that incorporating a
parameter that measures the joint action of obesity and
gender on hypertension status into the linkage analysis
significantly increases the linkage signal in several chro-
mosomal regions.
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Methods
In these analyses, we utilized the phenotypic and geno-
typic information provided for the Framingham real data
set. Individuals in Cohorts 1 and 2 were affected with
hypertension if their mean for all systolic blood pressure
(SBP) readings was ≥140 mm Hg or if they had at least one
documented use of antihypertensive medication. Analy-
ses conducted to check for pedigree and genotyping errors
using RELTEST and MARKERINFO [4], respectively, did
not reveal evidence of miss-specified relationships or non-
Mendelian segregation of marker genotypes.
Three covariates were incorporated into this analysis: BMI,
gender, and their interaction. BMI was calculated as the
weight in pounds divided by the height squared in inches
and multiplied by 703. Because there were up to 12 meas-
urements of BMI per individual, we defined five summary
BMI measurements: first, last, mean, slope, and predicted.
First and last BMI represent BMI measurements at the first
and last reported visits. Mean BMI is the average of all BMI
values for each individual. The slope (i.e., the change in
BMI over time) was the model coefficient obtained from
a linear regression of age on BMI within each individual.
Lastly, predicted BMI is the predicted value of BMI at age 50
from this linear regression. The BMI values were checked
for consistency and outliers. One height measurement
that was 2 feet less than the prior visit's measurement was
removed. The first, last, mean, and slope BMI were adjusted
for mean age and gender and predicted BMI was adjusted
only for gender. The residuals for all BMI measures were
used in subsequent linkage analyses. For all BMI measures
and gender, ARP-specific covariate values were generated
as the sum of the covariate values for the two individuals
in the ARP minus the sample mean. The interaction term
between BMI and gender was then obtained by multiply-
ing ARP-specific values of BMI and gender for each relative
pair.
We used the one-parameter conditional logistic model [3]
for ARP linkage analysis. This model is implemented in
the program LODPAL [4] and allows for the incorpora-
tion of covariates by fitting a single additional parameter
per covariate. In terms of the offspring recurrence-risk
ratio denoted as (λ1(x)), conditional on K covariates, xk,
the model is parameterized as λ1(x) = exp(β +  γkxk);
in terms of the recurrence-risk ratio for monozygotic
twins, denoted as λ2(x), it is parameterized as λ2(x) =
3.634 λ1(x) - 2.634. The number of alleles identical by
descent (IBD) was computed using multipoint algorithms
incorporated into GENIBD [4]. Ten pedigrees were too
large for multipoint computation using GENIBD, and
were split into two or three sub-pedigrees, resulting in 341
total pedigrees. P-values were obtained for the linkage
models using the asymptotic distribution of the likeli-
hood ratio tests. In this linkage analysis we define LOD
score as the likelihood ratio statistics divided by 4.605
(i.e., 2loge10).
We used backward selection to identify the most parsimo-
nious model at each location with suggestive evidence for
linkage defined as (p  < 0.001); i.e., covariates were
removed one at a time, starting with the gender by BMI
interaction. If the interaction term could not be removed,
both main effects were included in the final model. Cov-
ariates were retained in the model if the p-value for the
likelihood ratio test was < 0.05 (i.e., the likelihood of the
model with the covariate vs. the likelihood of the model
without the covariate).
Results
Of the 2898 individuals with a mean SBP reading, 1174
individuals (562 males and 612 females) were classified
as having hypertension, resulting in 263 affected sib pairs
(ASPs), and 450 ARPs available.
We identified significant evidence for linkage on chromo-
some 2 at 74 cM, and suggestive evidence of linkage on
chromosomes 1, 2 at 186 cM, 4, 12, 15, 18, 19, 20 and 22
(Table 1). Four measures of BMI (mean, first, last, and pre-
dicted) gave similar results, so we only report results for
mean BMI. Additionally, we report results for slope BMI,
which measures an individual's change in BMI over time.
For the baseline models (without covariates), there were
no regions with suggestive evidence of linkage. The high-
est LOD scores for the baseline models were on chromo-
somes 7 (LOD = 1.5, p = 0.004), 10 (LOD = 1.89, p =
0.002), and 12 (LOD = 1.68, p = 0.003). The only region
suggestive of linkage with BMI only as the covariate was
on 15q with mean BMI (Table 1 and Figure 1).
An interaction of BMI with gender is consistent with the
observations that the prevalence and age at onset distribu-
tions differ for hypertension between the sexes, and there
are reports of gender-specific effects for obesity [5], cho-
lesterol [6], and CVD [7]. The highest LOD score for the
interaction model was on chromosome 2. For this region,
individuals who are male and have a high BMI have the
highest sibling recurrence risk ratio (Table 2). Recurrence
risks were calculated using the model coefficients in Table
1, under the assumption that both sibs were 50 years of
age and had the same BMI using λs(x)= 1/4 + 1/2 λ1(x) +
1/4 λ2(x). To validate the signal on chromosome 2 we also
used the new Haseman-Elston regression equations as
implemented in SIBPAL [4]. In contrast to the LODPAL
analysis, this model utilizes discordant sib pairs in addi-
tion to the concordant sib pairs, and allows for the non-
independence among different types of sib pairs. When
implemented in SIBPAL [4] the interaction between
BMI*gender*  is highly significant (p = 0.009), giving
∑ = k
K
1
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further evidence to support the peak on chromosome 2
and the presence of locus heterogeneity measured by the
interaction of BMI and gender.
Other regions with suggestive evidence of linkage were
found on chromosomes 4 (LOD = 4.66) and 12 (LOD =
4.32). These regions consistently had high LOD scores
across the four BMI measures. The most parsimonious
model on chromosome 4 shows that the risk increases
with BMI in both genders, but is more pronounced in
males than in females, and on chromosome 12 the model
suggests that males with low BMI and females with high
BMI are at the greatest risk. We evaluated the recurrence
risk ratio at arbitrary ages for the sibs, and found that the
only region to demonstrate an effect of age was on chro-
mosome 18, where the recurrence risk ratio increases with
BMI in young males and older females.
The peak locations for BMI slope were different than the
peaks for the other BMI measures (Table 1). When the
BMI*gender interaction was included in the model, sug-
gestive evidence of linkage was found on chromosomes 1,
2, 4, 19, 20, and 22 (Table 1). Our strongest peak on chro-
mosome 22 is just below the cut-off for significant evi-
dence for linkage, and the region on chromosome 19 also
had suggestive evidence of linkage using the other BMI
measures (LOD scores from 3.12 to 3.92).
Conclusions
We have identified significant evidence of linkage to chro-
mosome 2p, and suggestive evidence of linkage on chro-
mosomes 1, 4, 12, 15, 18, 19, 20, and 22. The signal on
chromosome 2p replicates the findings of five previous
linkage studies including analyses of SBP in the GENOA
study [8] (p = 0.0193), diastolic blood pressure (DBP) in
the Quebec family study [9] (LOD = 1.02), and SBP in the
HERITAGE study [10] (LOD = 1.88) which report linkage
to D2S441 located 6 cM from our peak, and of SBP in the
NHLBI Heart Study [11] (LOD = 1.1) which reports a sig-
nal at 70 cM. In addition, Hunt et al. [11] report another
peak on this chromosome at 56 cM (LOD = 1.1) in hyper-
tensive ASPs. Also the NHLBI Family Blood Pressure Pro-
gram (FBPP) recently reported a LOD score of 3.09 at
marker D2S1788, using BMI as a covariate and perform-
ing the analysis with LODPAL [12]. Additionally, the peak
on chromosome 19 (BMI slope) is near the ApoE locus,
which has previously been associated with risk for hyper-
tension and CVD [7,13].
Candidate genes have not been evaluated in these regions,
with the exception of chromosome 12, in which a recent
case/control study, showed a significant association
between the T allele of G-Protein β3-Subunit (GNB3
~13.6 cM) and hypertensive subjects with increased BMI
[14]. Functional assays demonstrate an effect of this poly-
morphism, with enhanced activity for the T allele [15].
Interestingly, previous linkage studies have failed to iden-
tify this region, including that of Rice et al. [9], who typed
markers located within GNB3.
Our results differ substantially from the results of the pre-
vious genome scan in the Framingham Heart Study popu-
lation that utilized SBP as a quantitative trait [16]. We did
not identify the region on chromosome 17 reported by
Levy et al. [16], nor were the linkage signals detected in
this analysis identified in that study. Genes impacting the
normal variation in blood pressure (measured by SBP as a
quantitative trait) may be very distinct from genes impact-
ing extreme hypertension (measured as a discrete trait).
Table 1: Regions with at least suggestive linkage (p < 0.001) for the most parsimonious model
Chromosome 
(Location in cM)
Nearest Marker Lod Score (p-value) Model Coefficients
Mean BMI Slope BMI βγ GENDER γBMI γGENDER*BMI
2 (74 cM) D2S1352 7.1 (8.76 × 10-7) 0.000 -0.070 0.035 -0.059
4 (142 cM) D4S1644 4.7 (0.00017) 0.330 0.027 0.062 -0.052
12 (8 cM) D12S372 4.3 (0.00035) 0.030 -0.171 0.012 0.050
15 (128 cM) D15S642 4.1A(0.00004) 0.041 -0.041
18 (34 cM) D18S843 4.0 (0.00068) 0.229 -0.175 0.069 -0.050
1 (276 cM) D1S547 3.9 (0.00091) 0.087 -0.176 0.621 0.687
2 (186 cM) D2S1384 4.3 (0.00037) 0.000 -0.077 0.151 1.205
4 (194 cM) D4S2417 4.1 (0.00057) 0.000 -0.002 0.571 -1.134
19 (75 cM) D19S589 4.3 (0.00037) 0.018 -0.218 0.504 0.577
20 (74 cM) D20S481 4.0 (0.00072) 0.146 0.066 -0.783 -0.713
22 (48 cM) D22S445 5.7 (0.00001) 0.157 0.311 0.594 1.196
ALOD score for a model that includes BMI only. Otherwise, LOD scores are for the full model.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S45
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Genome scan plot Figure 1
Genome scan plot Genome scan results for hypertension including the baseline (no covariates), the mean BMI only, and the 
full (mean BMI, gender, and BMI*gender interaction) models. Suggestive evidence of linkage (p < 0.001) corresponds to a LOD 
score of 2.8 or 3.8 for the single covariate and full models respectively, and significant evidence of linkage (p < 0.00001) corre-
sponds to a LOD score 4.8 and 6.0, respectively.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S45
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Because slope BMI measured the individual change in BMI
over time, this covariate may have identified different sig-
nals associated with the normal variation in blood pres-
sure. It is interesting to note that the recurrence risk ratios
for slope BMI consistently (four out of six signals) showed
increasing risk for women with positive slopes, or women
who gain weight over time, while the other measures of
BMI did not show consistent linkage to either men or
women. Furthermore, it should be noted that we used a
linear regression equation to model slope BMI; however,
during the GAW13 meeting Strug et al. [17] demonstrated
that slope BMI did not fit a linear model, but was charac-
terized by a gain phase lasting to approximately age 55
followed by a less extreme decreasing phase in older age,
and our findings may change if we were to model slope
BMI in this fashion.
We demonstrate the importance of including covariates in
linkage analyses that may account for locus heterogeneity.
The significant linkage signals on chromosome 2, and
most of our other candidate regions, were not detected
without including the gender*BMI interaction term. The
signal on chromosome 2 is stronger in our analysis than
in previous reports and is not accounted for by differences
in sample size. It is noteworthy that we are able to detect
these signals despite using a broad definition of hyperten-
sion. The models developed in our analysis identify phe-
notypic characteristics of individuals likely to be linked to
each candidate region and suggest that complex traits such
as hypertension may have gender-specific components.
Our results show that some loci influencing hypertension
may have multiple additional interacting factors, reveal-
ing the complexity of the disease. This information facili-
tates the identification of target candidate genes and
molecular pathways for each region, and also aids in the
identification of appropriate populations for confirma-
tory studies.
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